CD4 and rheumatoid arthritis: It is characterized by joint inflammation, progressive joint destruction, and increasing disability.1 In past years, considerable therapeutic treatments have been used and functioned either by blocking pro-inflammatory cytokines or targeting cells that are closely involved in the pathophysiology of RA.2 T cells, especially CD4+ T cells, are supposed to play a central role in the development and progression of RA.